Osaka, Japan

Satoshi Itadani


 

Average Co-Inventor Count = 6.5

ph-index = 2

Forward Citations = 10(Granted Patents)


Location History:

  • Mishima-gun, JP (2010 - 2012)
  • Osaka, JP (2012 - 2020)

Company Filing History:


Years Active: 2010-2020

Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: Satoshi Itadani: Innovator in Trk-Inhibiting Compounds

Introduction

Satoshi Itadani is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of Trk-inhibiting compounds. With a total of 11 patents to his name, Itadani's work has the potential to impact the treatment of various Trk-related diseases.

Latest Patents

One of Itadani's latest patents involves a Trk-inhibiting compound that serves as a drug for the prophylaxis and therapy of Trk-related diseases. This invention provides a compound with Trk-inhibiting activity, which can be used to treat conditions such as pain, pruritus, lower urinary tract dysfunction, asthma, allergic rhinitis, inflammatory bowel disease, and Chagas disease. The compound is represented by a general formula, and its various forms, including salts and prodrugs, are also considered useful in therapeutic applications.

Another significant patent focuses on an acid-addition salt of a Trk-inhibiting compound. This invention aims to provide a therapeutic agent that selectively inhibits Trk activity while maintaining excellent solubility and absorbability. The compound is designed to persistently inhibit NGF vascular hyperpermeability without drug interactions, making it a valuable option for treating Trk-related diseases.

Career Highlights

Throughout his career, Satoshi Itadani has worked with notable companies in the pharmaceutical industry, including Ono Pharmaceutical Co., Ltd. and Ono Pharmaceuticals Co., Ltd. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Itadani has collaborated with esteemed colleagues such as Jun Takeuchi and Masahiro Ikura. These partnerships have likely enhanced his research and development efforts, leading to the successful creation of his patented compounds.

Conclusion

Satoshi Itadani is a distinguished inventor whose work in Trk-inhibiting compounds holds promise for advancing therapeutic options for various diseases. His innovative contributions and collaborations continue to shape the future of pharmaceutical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…